Enhanced response to caffeine and 4-chloro-m-cresol in malignant hyperthermia-susceptible muscle is related in part to chronically elevated resting [Ca2+]i

American Journal of Physiology - Cell Physiology

Volumn 288, Issue 3 57-3, 2005, Pages

  López, José R ^a,b   Linares, Nancy ^a   Pessah, Isaac N ^c   Allen, Paul D ^b  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1,2 bis(2 aminophenoxy)ethane N,N,N ,N tetraacetic acid; Calcium homeostasis

Indexed keywords

CAFFEINE; CALCIUM; CHLOROCRESOL;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; MALIGNANT HYPERTHERMIA; MEMBRANE POTENTIAL; MICROELECTRODE; MUSCLE CELL; NONHUMAN; POINT MUTATION; POLARIZATION AND DEPOLARIZATION; PRIORITY JOURNAL; SKELETAL MUSCLE; SWINE;

ANIMALS; ANIMALS, NEWBORN; CAFFEINE; CALCIUM; CENTRAL NERVOUS SYSTEM STIMULANTS; CHELATING AGENTS; CRESOLS; EGTAZIC ACID; ELECTROPHYSIOLOGY; FUNGICIDES, INDUSTRIAL; MALIGNANT HYPERTHERMIA; MEMBRANE POTENTIALS; MICROELECTRODES; MUSCLE, SKELETAL; SWINE;

EID: 13644264675     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00297.2004     Document Type: Article

References (52)

1. Aleman M, Riehl J, Aldridge BM, Lecouteur RA, Stott JL, and Pessah IN. Association of a mutation in the ryanodine receptor 1 gene with equine malignant hyperthermia. Muscle Nerve 30: 356-365, 2004.
2. Alvarez-Leefmans FJ, Rink TJ, and Tsien RY. Free calcium ions in neurones of Helix aspersa measured with ion-selective micro-electrodes. J Physiol 315: 531-548, 1981.
3. 2+-dependent mechanisms in cell homogenates from rabbit skeletal muscle. J Gen Physiol 105: 363-383, 1995.
4. 2+] signals from calcium-indicator dyes. News Physiol Sci 15: 19-26, 2000.
5. Boldin S, Jager U, Ruppersberg JP, Pentz S, and Rüdel R. Cultivation, morphology, and electrophysiology of contractile rat myoballs. Pflügers Arch 409: 462-467, 1987.
6. Brinkmeier H, Seewald MJ, Eichinger HM, and Rüdel R. Culture conditions for the production of porcine myotubes and myoballs. J Anim Sci 71: 1154-1160, 1993.
7. Carafoli E, Santella L, Branca D, and Brini M. Generation, control, and processing of cellular calcium signals. Crit Rev Biochem Mol Biol 36: 107-260, 2001.
8. Censier K, Urwyler A, Zorzato F, and Treves S. Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia- susceptible and normal individuals: effect of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors. J Clin Invest 101: 1233-1242, 1998.
9. Condrescu M, López JR, Medina P, and Alamo L. Deficient function of the sarcoplasmic reticulum in patients susceptible to malignant hyperthermia. Muscle Nerve 10: 238-241, 1987.
10. Ducreux S, Zorzato F, Müller C, Sewry C, Muntoni F, Quinlivan R, Restagno G, Girard T, and Treves S. Effect of ryanodine receptor mutations on IL6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease. J Biol Chem 279: 43838-43846, 2004.
11. Ervasti JM, Mickelson JR, and Louis CF. Transverse tubule calcium regulation in malignant hyperthermia. Arch Biochem Biophys 269: 497-506, 1989.
12. Foster PS, Gesini E, Claudianos C, Hopkinson KC, and Denborough MA. Inositol 1,4,5-trisphosphate phosphatase deficiency and malignant hyperpyrexia in swine. Lancet 2: 124-127, 1989.
13. Fujii J, Otsu K, Zorzato F, de Leon S, Khanna VK, Weiler JE, O'Brien PJ, and MacLennan DH. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 253: 448-451, 1991.
14. Gallant EM, Hart J, Eager K, Curtis S, and Dulhunty AF. Caffeine sensitivity of native RyR channels from normal and malignant hyperthermic pigs: effects of a DHPR II-III loop peptide. Am J Physiol Cell Physiol 286: C821-C830, 2004.
15. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
16. Herrmann-Frank A, Richter M, and Lehmann-Horn F. 4-Chloro-m-cresol: a specific tool to distinguish between malignant hyperthermia-susceptible and normal muscle. Biochem Pharmacol 52: 149-155, 1996.
17. Iaizzo PA, Klein W, and Lehmann-Horn F. Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs. Pflügers Arch 411: 648-653, 1988.
18. 2+] in human skeletal muscle. Cell Calcium 10: 151-158, 1989.
19. Jacquemond V, Csernoch L, Klein MG, and Schneider MF. Voltage-gated and calcium-gated calcium release during depolarization of skeletal muscle fibers. Biophys J 60: 867-873, 1991.
20. i in intact rat trabeculae. Am J Physiol Cell Physiol 273: C2046-C2056, 1997.
21. Jurkat-Rott K, McCarthy T, and Lehmann-Horn F. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 23: 4-17, 2000.
22. Kalow W, Britt BA, and Richter A. The caffeine test of isolated human muscle in relation to malignant hyperthermia. Can Anaesth Soc J 24: 678-694, 1977.
23. 2+ release from sarcoplasmic reticulum of normal and malignant hyperthermia susceptible pig muscles. Biochim Biophys Acta 775: 320-327, 1984.
24. 2+ entry into mouse skeletal muscle fibres. J Physiol 533: 185-199, 2001.
25. López JR, Alamo L, Caputo C, Vergara J, and DiPolo R. Direct measurement of intracellular free magnesium in frog skeletal muscle using magnesium-selective microelectrodes. Biochim Biophys Acta 804: 1-7, 1984.
26. 2+] during a malignant hyperthermia episode in swine. Muscle Nerve 11: 82-88, 1988.
27. 2+]. Anesthesiology 92: 1799-1806, 2000.
28. 2+] measured in vivo in patients susceptible to malignant hyperthermia. Anesthesiology 76: 711-719, 1992.
29. López JR, Perez C, Linares N, Allen P, and Terzic A. Hypersensitive response of malignant hyperthermia-susceptible skeletal muscle to inositol 1,4,5-triphosphate induced release of calcium. Naunyn Schmiedebergs Arch Pharmacol 352: 442-446, 1995.
30. i in chronically stimulated skeletal muscle. Acta Cient Venez 37: 699-700, 1986.
31. 2+-sensitive microelectrodes. Nature 286: 845-850, 1980.
32. Mickelson JR, Gallant EM, Litterer LA, Johnson KM, Rempel WE, and Louis CF. Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia. J Biol Chem 263: 9310-9315, 1988.
33. 2+ regulation defects. Physiol Rev 76: 537-592, 1996.
34. Mickelson JR, Ross JA, Hyslop RJ, Gallant EM, and Louis CF. Skeletal muscle sarcolemma in malignant hyperthermia: evidence for a defect in calcium regulation. Biochim Biophys Acta 897: 364-376, 1987.
35. 2+-induced calcium release by isolated sarcoplasmic reticulum vesicles from malignant hypothermia susceptible pig muscle. Biochim Biophys Acta 862: 318-328, 1986.
36. Minta A, Kao JP, and Tsien RY. Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J Biol Chem 264: 8171-8178, 1989.
37. ++ regulating proteins. Curr Mol Med 2: 347-369, 2002.
38. 2+ ions from human malignant hyperthermia-susceptible sarcoplasmic reticulum. Biochem Pharmacol 61: 1479-1485, 2001.
39. Richter M, Schleithoff L, Deufel T, Lehmann-Horn F, and Herrmann-Frank A. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle. J Biol Chem 272: 5256-5260, 1997.
40. 3H]uridine incorporation and stress-dependent transcription. Biochemistry 43: 9576-9582, 2004.
41. 2+ release channel. Am J Physiol Cell Physiol 267: C1253-C1261, 1994.
42. 2+ modulates charge movement in skeletal muscle. Gen Physiol Biophys 16: 59-77, 1997.
43. Takahashi A, Camacho P, Lechleiter JD, and Herman B. Measurement of intracellular calcium. Physiol Rev 79: 1089-1125, 1999.
44. 2+ channel. Anesthesiology 84: 1380-1385, 1996.
45. 2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease. J Biol Chem 272: 26332-26339, 1997.
46. Tsien RY. New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry 19: 2396-2404, 1980.
47. Tsien RY. Fluorescent probes of cell signaling. Annu Rev Neurosci 12: 227-253, 1989.
48. Wehner M, Rueffert H, Koenig F, Neuhaus J, and Olthoff D. Increased sensitivity to 4-chloro-m-cresol and caffeine in primary myotubes from malignant hyperthermia susceptible individuals carrying the ryanodine receptor 1 Thr2206Met (C6617T) mutation. Clin Genet 62: 135-146, 2002.
49. Wieland SJ, Fletcher JE, Rosenberg H, and Gong QH. Malignant hyperthermia: slow sodium current in cultured human muscle cells. Am J Physiol Cell Physiol 257: C759-C765, 1989.
50. 2+] is increased in myotubes expressing RyR1 cDNA with MH mutations (Abstract). Biophys J 84: 574A, 2003.
51. Yang T, Ta TA, Pessah IN, and Allen PD. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J Biol Chem 278: 25722-25730, 2003.
52. Yasin R, Van Beers G, Nurse KC, Al-Ani S, Landon DN, and Thompson EJ. A quantitative technique for growing human adult skeletal muscle in culture starting from mononucleated cells. J Neurol Sci 32: 347-360, 1977.